Merck & Co., Inc. logo
Merck & Co., Inc. (MRK)
Compare

Merck & Co., Inc. (MRK) EV/FCF Ratio: 23.85x

popular:market cap|pe ratio|revenue|price history|total return

Is Merck & Co., Inc.’s EV/FCF ratio high or low?

Merck & Co., Inc.'s EV/FCF ratio of 23.85x is in line with its 5-year average of 23.71x, around the middle of its 5-year range (12.12x–44.53x).

The EV/FCF ratio for Merck & Co., Inc. (MRK) is 23.85x as of Wednesday, June 10, 2026. It is above its 12-month average by 17.75% (20.25x).

Free Cash Flow|FCF Yield|P/FCF Ratio|EV/EBITDA|All Metrics

MRK EV/FCF Ratio Chart

MRK EV/FCF Ratio
23.85x+75.11% 1Y
Zoom

MRK Average EV/FCF Ratio Chart

MRK Current vs Average EV/FCF Ratio Chart

MRK EV/FCF Ratio Metrics

EV/FCF RATIO

23.85x

EV/FCF RATIO AVG TTM

20.25x

EV/FCF RATIO AVG 3Y

23.16x

EV/FCF RATIO AVG 5Y

23.71x

EV/FCF RATIO AVG 10Y

25.36x

EV/FCF RATIO AVG 15Y

22.97x

EV/FCF RATIO AVG 20Y

22.81x

CURRENT VS TTM AVG

+17.75%

CURRENT VS 3Y AVG

+2.98%

CURRENT VS 5Y AVG

+0.59%

CURRENT VS 10Y AVG

-5.96%

CURRENT VS 15Y AVG

+3.81%

CURRENT VS 20Y AVG

+4.54%

MRK Competitors' EV/FCF Ratio

NAMEMARKET CAPEV/FCF RATIOTTM3Y5Y
Merck & Co., Inc. (MRK)$293.02B23.85x20.25x23.16x23.71x
UnitedHealth Group Incorporated (UNH)$368.44B21.34x17.58x29.12x26.09x
AbbVie Inc. (ABBV)$399.54B22.25x23.70x20.02x17.81x
Amgen Inc. (AMGN)$183.75B26.79x22.34x24.94x22.49x
Thermo Fisher Scientific Inc. (TMO)$179.45B32.61x35.72x34.62x34.75x
Abbott Laboratories (ABT)$154.66B24.72x31.00x34.91x31.02x
Gilead Sciences, Inc. (GILD)$151.21B16.34x18.52x16.04x14.51x
Intuitive Surgical, Inc. (ISRG)$146.44B51.80x79.78x160.45x125.16x
Pfizer Inc. (PFE)$146.36B22.12x19.75x27.32x21.37x
Danaher Corporation (DHR)$130.25B27.20x31.97x32.30x30.49x

Cash Flow Valuation Comparison

EV/FCF

23.9x

P/FCF

20.8x

FCF Yield

4.82%

Formula: EV/FCF = Enterprise Value / Free Cash Flow

EV/FCF vs P/FCF:

  • EV/FCF accounts for debt and cash through enterprise value
  • P/FCF only considers equity value
  • EV/FCF can be compared across companies with different debt levels
  • Both measure how the market values cash generation

Merck & Co., Inc. EV/FCF Ratio Formula & Definition

EV/FCF = Enterprise Value / Free Cash Flow (TTM)

Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Merck & Co., Inc. EV/FCF Ratio FAQ

What is the EV/FCF ratio for Merck & Co., Inc. (MRK)?
The EV/FCF ratio for MRK stock is 23.85x.
Is Merck & Co., Inc.'s EV/FCF ratio high or low?
Merck & Co., Inc.'s EV/FCF ratio of 23.85x is in line with its 5-year average of 23.71x, around the middle of its 5-year range (12.12x–44.53x).
What is the TTM average EV/FCF ratio for Merck & Co., Inc. (MRK)?
The TTM average EV/FCF ratio for MRK stock is 20.25x.
What is the 3Y average EV/FCF ratio for Merck & Co., Inc. (MRK)?
The 3Y average EV/FCF ratio for MRK stock is 23.16x.
What is the 5Y average EV/FCF ratio for Merck & Co., Inc. (MRK)?
The 5Y average EV/FCF ratio for MRK stock is 23.71x.
What is the 10Y average EV/FCF ratio for Merck & Co., Inc. (MRK)?
The 10Y average EV/FCF ratio for MRK stock is 25.36x.
What is the 15Y average EV/FCF ratio for Merck & Co., Inc. (MRK)?
The 15Y average EV/FCF ratio for MRK stock is 22.97x.
What is the 20Y average EV/FCF ratio for Merck & Co., Inc. (MRK)?
The 20Y average EV/FCF ratio for MRK stock is 22.81x.

Merck & Co., Inc. EV/FCF Ratio History

DATEEV/FCF RATIO
2026-06-1023.85x
2026-06-0924.05x
2026-06-0824.03x
2026-06-0524.26x
2026-06-0424.16x
2026-06-0323.19x
2026-06-0223.36x
2026-06-0123.27x
2026-05-2923.89x
2026-05-2824.10x
2026-05-2724.16x
2026-05-2624.07x
2026-05-2224.54x
2026-05-2123.40x
2026-05-2022.89x
2026-05-1923.11x
2026-05-1822.82x
2026-05-1522.61x
2026-05-1422.96x
2026-05-1322.97x
2026-05-1222.78x
2026-05-1122.59x
2026-05-0822.61x
2026-05-0722.77x
2026-05-0622.99x
2026-05-0522.92x
2026-05-0422.91x
2026-05-0125.49x
2026-04-3024.89x
2026-04-2925.24x
2026-04-2825.06x
2026-04-2725.10x
2026-04-2425.43x
2026-04-2325.98x
2026-04-2225.63x
2026-04-2125.57x
2026-04-2026.48x
2026-04-1726.88x
2026-04-1626.15x
2026-04-1526.64x
2026-04-1427.06x
2026-04-1327.10x
2026-04-1027.35x
2026-04-0927.60x
2026-04-0827.71x
2026-04-0726.92x
2026-04-0627.24x
2026-04-0227.24x
2026-04-0127.23x
2026-03-3127.12x
2026-03-3026.68x
2026-03-2726.99x
2026-03-2626.85x
2026-03-2526.94x
2026-03-2426.33x
2026-03-2326.20x
2026-03-2025.89x
2026-03-1925.90x
2026-03-1825.96x
2026-03-1726.23x
2026-03-1626.15x
2026-03-1326.18x
2026-03-1226.24x
2026-03-1126.30x
2026-03-1026.48x
2026-03-0926.48x
2026-03-0626.22x
2026-03-0526.27x
2026-03-0427.12x
2026-03-0327.03x
2026-03-0227.35x
2026-02-2727.83x
2026-02-2626.92x
2026-02-2527.56x
2026-02-2427.86x
2026-02-2325.48x
2026-02-2025.18x
2026-02-1925.11x
2026-02-1825.07x
2026-02-1725.05x
2026-02-1325.02x
2026-02-1224.60x
2026-02-1124.61x
2026-02-1024.20x
2026-02-0924.30x
2026-02-0625.12x
2026-02-0524.70x
2026-02-0424.43x
2026-02-0323.95x
2026-02-0223.48x
2026-01-3022.89x
2026-01-2922.52x
2026-01-2822.24x
2026-01-2722.44x
2026-01-2622.34x
2026-01-2322.49x
2026-01-2222.68x
2026-01-2123.05x
2026-01-2022.73x
2026-01-1622.61x
2026-01-1523.02x
2026-01-1423.03x
2026-01-1322.50x
2026-01-1222.68x
2026-01-0922.94x
2026-01-0823.03x
2026-01-0722.57x
2026-01-0622.62x
2026-01-0522.35x
2026-01-0222.16x
2025-12-3121.93x
2025-12-3022.08x
2025-12-2922.19x
2025-12-2622.22x
2025-12-2422.16x
2025-12-2321.89x
2025-12-2221.83x
2025-12-1921.13x
2025-12-1821.05x
2025-12-1720.76x
2025-12-1620.59x
2025-12-1520.97x
2025-12-1220.98x
2025-12-1120.73x
2025-12-1020.47x
2025-12-0920.33x
2025-12-0820.72x
2025-12-0520.87x
2025-12-0421.09x
2025-12-0321.36x
2025-12-0221.12x
2025-12-0121.27x
2025-11-2821.85x
2025-11-2621.81x
2025-11-2522.01x
2025-11-2421.00x
2025-11-2120.49x
2025-11-2019.96x
2025-11-1919.97x
2025-11-1820.24x
2025-11-1719.55x
2025-11-1419.57x
2025-11-1319.57x
2025-11-1219.28x
2025-11-1119.19x
2025-11-1018.39x
2025-11-0718.30x
2025-11-0618.20x
2025-11-0517.93x
2025-11-0416.18x
2025-11-0315.94x
2025-10-3116.54x
2025-10-3016.59x
2025-10-2916.64x
2025-10-2816.72x
2025-10-2716.88x
2025-10-2416.80x
2025-10-2316.74x
2025-10-2216.82x
2025-10-2116.82x
2025-10-2016.60x
2025-10-1716.33x
2025-10-1616.19x
2025-10-1516.22x
2025-10-1416.32x
2025-10-1316.49x
2025-10-1016.54x
2025-10-0916.80x
2025-10-0816.61x
2025-10-0716.82x
2025-10-0617.02x
2025-10-0317.09x
2025-10-0217.14x
2025-10-0117.25x
2025-09-3016.19x
2025-09-2915.27x
2025-09-2615.27x
2025-09-2515.11x
2025-09-2415.46x
2025-09-2315.51x
2025-09-2215.58x
2025-09-1915.77x
2025-09-1815.78x
2025-09-1715.71x
2025-09-1615.70x
2025-09-1515.69x
2025-09-1216.00x
2025-09-1116.40x
2025-09-1016.20x
2025-09-0916.30x
2025-09-0816.21x
2025-09-0516.32x
2025-09-0416.21x
2025-09-0316.23x
2025-09-0216.45x
2025-08-2916.22x
2025-08-2816.06x
2025-08-2716.21x
2025-08-2616.37x
2025-08-2516.42x
2025-08-2216.77x
2025-08-2116.55x
2025-08-2016.31x
2025-08-1916.36x
2025-08-1816.24x
2025-08-1516.24x
2025-08-1415.99x
2025-08-1315.98x
2025-08-1215.57x
2025-08-1115.52x
2025-08-0815.63x
2025-08-0715.58x
2025-08-0615.42x
2025-08-0515.65x
2025-08-0413.40x
2025-08-0113.32x
2025-07-3113.14x
2025-07-3013.68x
2025-07-2913.81x
2025-07-2814.02x
2025-07-2514.12x
2025-07-2414.03x
2025-07-2314.01x
2025-07-2213.66x
2025-07-2113.32x
2025-07-1813.42x
2025-07-1713.65x
2025-07-1613.78x
2025-07-1513.65x
2025-07-1413.97x
2025-07-1113.92x
2025-07-1014.02x
2025-07-0913.97x
2025-07-0813.63x
2025-07-0713.56x
2025-07-0313.56x
2025-07-0213.78x
2025-07-0113.69x
2025-06-3013.30x
2025-06-2713.29x
2025-06-2613.25x
2025-06-2513.37x
2025-06-2413.47x
2025-06-2313.45x
2025-06-2013.28x
2025-06-1813.32x
2025-06-1713.17x
2025-06-1613.56x
2025-06-1313.68x
2025-06-1213.69x
2025-06-1113.47x
2025-06-1013.62x
2025-06-0913.32x
2025-06-0613.27x
2025-06-0513.07x
2025-06-0413.16x
2025-06-0313.00x
2025-06-0212.86x
2025-05-3012.95x
2025-05-2912.89x

Showing the most recent 260 of 5,031 data points. The chart above shows the full history.

Related Metrics

Free Cash FlowFCF YieldP/FCF RatioEV/EBITDAAll Metrics

About Merck & Co., Inc.

Merck & Co., Inc. is a global healthcare leader with operations spanning two core divisions: Pharmaceuticals and Animal Health. The Pharmaceutical segment is dedicated to human health, offering a broad spectrum of medicinal products. These cover crucial therapeutic areas such as oncology, acute hospital care, immunology, neuroscience, virology, cardiovascular conditions, and diabetes. This division also develops vital preventive vaccines for pediatric, adolescent, and adult populations. Meanwhile, the Animal Health segment focuses on the research, development, manufacturing, and marketing of veterinary medications, vaccines, and comprehensive health management solutions for animals. This division further provides innovative digital products designed for animal identification, traceability, and continuous monitoring. Merck's extensive clientele encompasses drug wholesalers, pharmacies, hospitals, and government agencies. It also serves managed healthcare organizations, including health maintenance organizations (HMOs) and pharmacy benefit managers, as well as various other institutional clients. Additionally, the company supplies products to individual physicians and their distributors, veterinarians, and livestock producers. The organization actively engages in strategic collaborations with companies such as AstraZeneca PLC, Bayer AG, Eisai Co., Ltd., Ridgeback Biotherapeutics, and Gilead Sciences, Inc. These partnerships are specifically aimed at the joint development and commercialization of prolonged-acting therapies for HIV. Established in 1891, Merck & Co., Inc. maintains its corporate headquarters in Kenilworth, New Jersey.

Rahway, NJ
73,000 employees
www.merck.com
Healthcare / Drug Manufacturers - General
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Robert Davis
View full financials